Evaluation of the protective role of resveratrol on LPS-induced septic intestinal barrier function via TLR4/MyD88/NF-κB signaling pathways

Abstract The intestinal barrier function is a critical defense mechanism in the human body, serving as both the primary target and initiating organ in cases of sepsis. Preserving the integrity of this barrier is essential for preventing complications and diseases, including sepsis and mortality. Des...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhongliang Shi, Yanna Jiao, Zhizhen Lai, Juan Liu, Bo Yang, Mahong Hu, Jianbiao Meng
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-85148-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559656690876416
author Zhongliang Shi
Yanna Jiao
Zhizhen Lai
Juan Liu
Bo Yang
Mahong Hu
Jianbiao Meng
author_facet Zhongliang Shi
Yanna Jiao
Zhizhen Lai
Juan Liu
Bo Yang
Mahong Hu
Jianbiao Meng
author_sort Zhongliang Shi
collection DOAJ
description Abstract The intestinal barrier function is a critical defense mechanism in the human body, serving as both the primary target and initiating organ in cases of sepsis. Preserving the integrity of this barrier is essential for preventing complications and diseases, including sepsis and mortality. Despite this importance, the impact of resveratrol on intestinal barrier function remains unclear. Thus, this study aims to explore the potential beneficial effects of resveratrol on maintaining intestinal barrier function. Fifteen male Sprague Dawley rats, weighing between 180 g and 220 g, were randomly assigned to one of three groups: the control group (Con), the lipopolysaccharide (LPS) group, and the resveratrol (RSV) group. The resveratrol group received an intravenous administration of resveratrol at a dosage of 8 mg/kg, 10 min prior to lipopolysaccharide treatment. Each group comprised five rats. Various techniques including enzyme-linked immunosorbent assay (ELISA), hematoxylin and eosin staining (HE), periodic acid Schiff (PAS) staining, transmission electron microscopy (TEM), Western blot analysis (WB), and quantitative real-time polymerase chain reaction (qRT-PCR) were utilized to assess differences in inflammatory cytokine expression, histopathological changes, apoptosis, tight junction (TJ) protein, and the TLR4/MyD88/NF-кB signaling pathways. Resveratrol exhibited anti-inflammatory effects by decreasing levels of interleukin (IL)-1β, interleukin(IL)-6, and tumor necrosis factor (TNF)-α, while increasing interleukin (IL)-10. Additionally, in rats treated with resveratrol, there was a reduction in the expression of apoptosis-associated proteins Bax and Caspase-3. Resveratrol also significantly increased the expression of intestinal tight junction proteins (TJ), and decreased the levels of intestinal fatty acid binding protein (I-FABP) and D-lactic acid (D-LA). Furthermore, the expression of proteins in the related signaling pathways TLR4, MyD88, and NF-κB was decreased. Resveratrol has been shown to reduce the expression of intestinal apoptotic proteins, enhance the expression of intestinal tight junction proteins, and inhibit the inflammatory response mediated by the TLR4/MyD88/NF-κB signaling pathway, thereby alleviating LPS-induced septic intestinal injury.
format Article
id doaj-art-4bf027a575ef4def99568e274ae2be37
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-4bf027a575ef4def99568e274ae2be372025-01-05T12:18:39ZengNature PortfolioScientific Reports2045-23222025-01-0115111210.1038/s41598-025-85148-2Evaluation of the protective role of resveratrol on LPS-induced septic intestinal barrier function via TLR4/MyD88/NF-κB signaling pathwaysZhongliang Shi0Yanna Jiao1Zhizhen Lai2Juan Liu3Bo Yang4Mahong Hu5Jianbiao Meng6Department of Critical Care Medicine, Tongde Hospital of Zhejiang ProvinceDepartment of Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of MedicineDepartment of Critical Care Medicine, Tongde Hospital of Zhejiang ProvinceDepartment of Nephrology, Hangzhou Linping Hospital of Traditional Chinese MedicineDepartment of Critical Care Medicine, Tongde Hospital of Zhejiang ProvinceDepartment of Critical Care Medicine, Tongde Hospital of Zhejiang ProvinceDepartment of Critical Care Medicine, Tongde Hospital of Zhejiang ProvinceAbstract The intestinal barrier function is a critical defense mechanism in the human body, serving as both the primary target and initiating organ in cases of sepsis. Preserving the integrity of this barrier is essential for preventing complications and diseases, including sepsis and mortality. Despite this importance, the impact of resveratrol on intestinal barrier function remains unclear. Thus, this study aims to explore the potential beneficial effects of resveratrol on maintaining intestinal barrier function. Fifteen male Sprague Dawley rats, weighing between 180 g and 220 g, were randomly assigned to one of three groups: the control group (Con), the lipopolysaccharide (LPS) group, and the resveratrol (RSV) group. The resveratrol group received an intravenous administration of resveratrol at a dosage of 8 mg/kg, 10 min prior to lipopolysaccharide treatment. Each group comprised five rats. Various techniques including enzyme-linked immunosorbent assay (ELISA), hematoxylin and eosin staining (HE), periodic acid Schiff (PAS) staining, transmission electron microscopy (TEM), Western blot analysis (WB), and quantitative real-time polymerase chain reaction (qRT-PCR) were utilized to assess differences in inflammatory cytokine expression, histopathological changes, apoptosis, tight junction (TJ) protein, and the TLR4/MyD88/NF-кB signaling pathways. Resveratrol exhibited anti-inflammatory effects by decreasing levels of interleukin (IL)-1β, interleukin(IL)-6, and tumor necrosis factor (TNF)-α, while increasing interleukin (IL)-10. Additionally, in rats treated with resveratrol, there was a reduction in the expression of apoptosis-associated proteins Bax and Caspase-3. Resveratrol also significantly increased the expression of intestinal tight junction proteins (TJ), and decreased the levels of intestinal fatty acid binding protein (I-FABP) and D-lactic acid (D-LA). Furthermore, the expression of proteins in the related signaling pathways TLR4, MyD88, and NF-κB was decreased. Resveratrol has been shown to reduce the expression of intestinal apoptotic proteins, enhance the expression of intestinal tight junction proteins, and inhibit the inflammatory response mediated by the TLR4/MyD88/NF-κB signaling pathway, thereby alleviating LPS-induced septic intestinal injury.https://doi.org/10.1038/s41598-025-85148-2ResveratrolSepsisIntestinal barrier dysfunctionApoptosisTight junctionTLR4/MyD88/NF-κB signaling pathway
spellingShingle Zhongliang Shi
Yanna Jiao
Zhizhen Lai
Juan Liu
Bo Yang
Mahong Hu
Jianbiao Meng
Evaluation of the protective role of resveratrol on LPS-induced septic intestinal barrier function via TLR4/MyD88/NF-κB signaling pathways
Scientific Reports
Resveratrol
Sepsis
Intestinal barrier dysfunction
Apoptosis
Tight junction
TLR4/MyD88/NF-κB signaling pathway
title Evaluation of the protective role of resveratrol on LPS-induced septic intestinal barrier function via TLR4/MyD88/NF-κB signaling pathways
title_full Evaluation of the protective role of resveratrol on LPS-induced septic intestinal barrier function via TLR4/MyD88/NF-κB signaling pathways
title_fullStr Evaluation of the protective role of resveratrol on LPS-induced septic intestinal barrier function via TLR4/MyD88/NF-κB signaling pathways
title_full_unstemmed Evaluation of the protective role of resveratrol on LPS-induced septic intestinal barrier function via TLR4/MyD88/NF-κB signaling pathways
title_short Evaluation of the protective role of resveratrol on LPS-induced septic intestinal barrier function via TLR4/MyD88/NF-κB signaling pathways
title_sort evaluation of the protective role of resveratrol on lps induced septic intestinal barrier function via tlr4 myd88 nf κb signaling pathways
topic Resveratrol
Sepsis
Intestinal barrier dysfunction
Apoptosis
Tight junction
TLR4/MyD88/NF-κB signaling pathway
url https://doi.org/10.1038/s41598-025-85148-2
work_keys_str_mv AT zhongliangshi evaluationoftheprotectiveroleofresveratrolonlpsinducedsepticintestinalbarrierfunctionviatlr4myd88nfkbsignalingpathways
AT yannajiao evaluationoftheprotectiveroleofresveratrolonlpsinducedsepticintestinalbarrierfunctionviatlr4myd88nfkbsignalingpathways
AT zhizhenlai evaluationoftheprotectiveroleofresveratrolonlpsinducedsepticintestinalbarrierfunctionviatlr4myd88nfkbsignalingpathways
AT juanliu evaluationoftheprotectiveroleofresveratrolonlpsinducedsepticintestinalbarrierfunctionviatlr4myd88nfkbsignalingpathways
AT boyang evaluationoftheprotectiveroleofresveratrolonlpsinducedsepticintestinalbarrierfunctionviatlr4myd88nfkbsignalingpathways
AT mahonghu evaluationoftheprotectiveroleofresveratrolonlpsinducedsepticintestinalbarrierfunctionviatlr4myd88nfkbsignalingpathways
AT jianbiaomeng evaluationoftheprotectiveroleofresveratrolonlpsinducedsepticintestinalbarrierfunctionviatlr4myd88nfkbsignalingpathways